Synexa Life Sciences enrolls in My Green Lab Certification Program
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
This product will be manufactured at Lupin’s Pithampur facility in India
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Ibara will drive AI-powered clinical research innovation
Subscribe To Our Newsletter & Stay Updated